JP2004501888A5 - - Google Patents

Download PDF

Info

Publication number
JP2004501888A5
JP2004501888A5 JP2002505343A JP2002505343A JP2004501888A5 JP 2004501888 A5 JP2004501888 A5 JP 2004501888A5 JP 2002505343 A JP2002505343 A JP 2002505343A JP 2002505343 A JP2002505343 A JP 2002505343A JP 2004501888 A5 JP2004501888 A5 JP 2004501888A5
Authority
JP
Japan
Prior art keywords
methoxyphenyl
compound
pharmaceutical composition
methoxycarbonyl
cor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002505343A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004501888A (ja
Filing date
Publication date
Priority claimed from IT2000RM000341A external-priority patent/IT1317049B1/it
Application filed filed Critical
Publication of JP2004501888A publication Critical patent/JP2004501888A/ja
Publication of JP2004501888A5 publication Critical patent/JP2004501888A5/ja
Pending legal-status Critical Current

Links

JP2002505343A 2000-06-23 2001-06-15 ホスホジエステラーゼiv阻害活性を有する薬剤の調製に有用な化合物 Pending JP2004501888A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000RM000341A IT1317049B1 (it) 2000-06-23 2000-06-23 Composti utili per la preparazione di medicamenti ad attivita'inibitrice della fosfodiesterasi iv.
PCT/IT2001/000312 WO2002000593A2 (en) 2000-06-23 2001-06-15 Compounds useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity

Publications (2)

Publication Number Publication Date
JP2004501888A JP2004501888A (ja) 2004-01-22
JP2004501888A5 true JP2004501888A5 (enExample) 2008-08-07

Family

ID=11454800

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002505343A Pending JP2004501888A (ja) 2000-06-23 2001-06-15 ホスホジエステラーゼiv阻害活性を有する薬剤の調製に有用な化合物

Country Status (13)

Country Link
US (1) US7169808B2 (enExample)
EP (1) EP1292563A2 (enExample)
JP (1) JP2004501888A (enExample)
KR (1) KR100764885B1 (enExample)
AU (1) AU2001269420A1 (enExample)
CA (1) CA2411162A1 (enExample)
CZ (1) CZ20023948A3 (enExample)
HU (2) HUP0301205A3 (enExample)
IT (1) IT1317049B1 (enExample)
MX (1) MXPA02012589A (enExample)
PL (1) PL359409A1 (enExample)
SK (1) SK17302002A3 (enExample)
WO (1) WO2002000593A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7312247B2 (en) * 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7842727B2 (en) 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US8026280B2 (en) * 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
EP1511477A4 (en) 2002-05-22 2008-04-09 Errant Gene Therapeutics Llc HISTONE DEACETYLASE INHIBITORS BASED ON ALPHA-KETO-EPOXYDE COMPOUNDS
AU2003291097A1 (en) * 2002-11-20 2004-06-15 Errant Gene Therapeutics, Llc Treatment of lung cells with histone deacetylase inhibitors
US20080132539A1 (en) * 2003-12-25 2008-06-05 Junji Kakuchi Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative
GB0818907D0 (en) * 2008-10-15 2008-11-19 Isis Innovation Histone lysine demethylase inhibitors
EP3691634A4 (en) 2017-10-05 2021-03-31 Biogen Inc. PROCESS FOR THE PREPARATION OF PYRROLIDINE ALPHA-CARBOXAMIDE DERIVATIVES
MX2021012421A (es) * 2019-04-10 2022-02-10 Biogen Inc Procesos para preparar derivados de pirrolidina alfa-carboxamida.

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3714356A (en) * 1971-01-18 1973-01-30 Morton Norwich Products Inc Antibacterial composition and method
GB1419968A (en) 1972-12-21 1975-12-31 Wyeth John & Brother Ltd Aziridine derivatives
AU6889274A (en) * 1973-05-17 1975-11-20 Astra Laekemedel Ab Treatment of neurological disorders
DE3160641D1 (en) * 1980-05-13 1983-08-25 Ciba Geigy Ag Process for the preparation of benzene or naphthalene alkenyl carboxylic acid derivatives
US4820828A (en) * 1987-03-04 1989-04-11 Ortho Pharmaceutical Corporation Cinnamohydroxamic acids
US4971959A (en) * 1987-04-14 1990-11-20 Warner-Lambert Company Trisubstituted phenyl analogs having activity for congestive heart failure
US5232735A (en) * 1990-06-01 1993-08-03 Bioresearch, Inc. Ingestibles containing substantially tasteless sweetness inhibitors as bitter taste reducers or substantially tasteless bitter inhibitors as sweet taste reducers
IL98764A0 (en) 1990-07-10 1992-07-15 Smithkline Beecham Corp Oxamides
US5191084A (en) * 1991-05-01 1993-03-02 American Home Products Corporation Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents
PT100441A (pt) 1991-05-02 1993-09-30 Smithkline Beecham Corp Pirrolidinonas, seu processo de preparacao, composicoes farmaceuticas que as contem e uso
US5665754A (en) * 1993-09-20 1997-09-09 Glaxo Wellcome Inc. Substituted pyrrolidines
KR100332273B1 (ko) * 1995-07-26 2002-06-20 디. 제이. 우드, 스피겔 알렌 제이 엔-(아로일)글리신하이드록삼산유도체및이와관련된화합물
US5922771A (en) * 1995-07-26 1999-07-13 Takeda Chemical Industries, Ltd. Benzocycloalkene compounds, their production and use
JP4017214B2 (ja) * 1996-06-11 2007-12-05 興和創薬株式会社 5−フェニル−3−ピリダジノン誘導体
DK0918746T3 (da) * 1996-08-12 2003-08-04 Celgene Corp Immunterapeutiske midler og deres anvendelse til reduktion af cytokinniveauer
GB9618349D0 (en) * 1996-09-03 1996-10-16 Pharmacia Spa N-substituted 2-amino-4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibitory activity
AR017014A1 (es) 1997-07-22 2001-08-22 Astrazeneca Ab Compuestos de triazolo [4,5-d]pirimidina, composiciones farmaceuticas, uso de los mismos para preparar medicamentos y procesos para la preparacionde dichos compuestos
IT1294931B1 (it) 1997-09-22 1999-04-23 Sigma Tau Ind Farmaceuti Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella
WO1999030709A1 (en) 1997-12-17 1999-06-24 Merck & Co., Inc. Integrin receptor antagonists
US6028116A (en) * 1998-04-03 2000-02-22 Cell Pathways, Inc. Substituted condensation products of 1H-indenyl-hydroxyalkanes with aldehydes for neoplasia
IL143577A0 (en) * 1998-12-14 2002-04-21 Fujisawa Pharmaceutical Co Piperazine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
DE19952146A1 (de) * 1999-10-29 2001-06-07 Boehringer Ingelheim Pharma Arylalkane, Arylalkene und Aryl-azaalkane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung

Similar Documents

Publication Publication Date Title
JP2002508347A5 (enExample)
RU2335493C2 (ru) Производные хинолина в качестве ингибиторов фосфодиэстеразы
JP2004533450A5 (enExample)
JP2004501888A5 (enExample)
EP2186792A8 (en) 2-(a-hydroxypentyl) benzoate and its preparation and use
CA2614529A1 (en) Pyridazinone derivatives as thyroid hormone receptor agonists
JP2010530881A5 (enExample)
JP2006509749A5 (enExample)
JP2006506425A5 (enExample)
JP2005511697A5 (enExample)
JP2005524605A5 (enExample)
JP2002509153A5 (enExample)
JP2005530852A5 (enExample)
JP2004509837A5 (enExample)
WO1996018606A1 (en) Novel 1,3-dialkylurea derivatives
JP2005521721A5 (enExample)
JP2004532828A5 (enExample)
JP2003515583A5 (enExample)
JP2005513014A5 (enExample)
JP2006503816A5 (enExample)
CA2433039A1 (en) Agent for therapeutic and prophylactic treatment of neuropathic pain
JP2002526530A5 (enExample)
JP2004538314A5 (enExample)
JP2004524357A5 (enExample)
JP2019536778A5 (enExample)